amotosalen has been researched along with Black Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beverley, SM; Birnbaum, R; Bruhn, KW; Chang, PL; Craft, N; Greger, S; Haskell, J; Hickerson, SM; Narayan, R; Tran, TA; Vanchinathan, V; Wilson, ME | 1 |
| Fisa, R; Girona-Llobera, E; Guillen, C; Iniesta, L; Jimenez-Marco, T; Muncunill, J; Riera, C; Saura, A; Sedeño, M | 1 |
2 other study(ies) available for amotosalen and Black Fever
| Article | Year |
|---|---|
Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis.
Topics: Animal Structures; Animals; Anti-Infective Agents, Local; Female; Furocoumarins; Leishmania infantum; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Ultraviolet Rays; Vaccines, Inactivated | 2012 |
Pathogen inactivation technology applied to a blood component collected from an asymptomatic carrier of Leishmania infantum: a case report.
Topics: Asymptomatic Infections; Blood Transfusion; Carrier State; Furocoumarins; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Middle Aged; Ultraviolet Rays | 2012 |